IRVINE, Calif.--(BUSINESS WIRE)--Pegasus Biologics, Inc., a privately held developer of unique collagen scaffolds for soft tissue repair, announced today that it has received CE Mark certification for the EU commercial sale of its Unite™ Biomatrix collagen wound dressing for treatment of diabetic foot ulcers.
